Ixazomib citrate (MLN9708) is a selective, orally active, second-generation proteasome inhibitor. Ixazomib citrate can be used for the study of a broad range of human malignancies[1][2][3].
Molecular Weight:
517.12
Purity:
99.89
CAS Number:
[1239908-20-3]
Formula:
C20H23BCl2N2O9
Target:
Autophagy,Proteasome
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
